Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease
- 17 April 2002
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 326 (1) , 70-72
- https://doi.org/10.1016/s0304-3940(02)00301-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patientsPublished by Elsevier ,2003
- A Single Question about Prior Stroke versus a Stroke Questionnaire to Assess Stroke Prevalence in PopulationsNeuroepidemiology, 2000
- Association of an interleukin 1α polymorphism with Alzheimer’s diseaseNeurology, 2000
- Interleukin (IL)-1?, IL-1?, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsyAnnals of Neurology, 2000
- Genetic analysis of immunomodulating factors in sporadic Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2000
- Association of early-onset Alzheimer's disease with an interleukin-1? gene polymorphismAnnals of Neurology, 2000
- Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson diseaseProceedings of the National Academy of Sciences, 1997
- Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's diseaseNeuroscience Letters, 1996
- Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's diseaseNeuroscience Letters, 1994
- Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patientsNeuroscience Letters, 1994